Patents by Inventor Peter MILBURN

Peter MILBURN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS AND USES THEREOF
    Publication number: 20220040280
    Abstract: Disclosed are lysine specific histone demethylase-1 (LSD1) inhibitors in methods and compositions for immune check-point inhibition. The invention also relates to proteinaceous molecules and their use in altering at least one of (i) formation, (ii) 5 N proliferation, (iii) maintenance, (iv) epithelial to mesenchymal cell transition (EMT), or (v) mesenchymal to epithelial cell transition (MET) of an LSD1 overexpressing cell.
    Type: Application
    Filed: September 7, 2017
    Publication date: February 10, 2022
    Inventors: Sudha RAO, Peter MILBURN
  • PROTEINACEOUS MOLECULES AND USES THEREFOR
    Publication number: 20200339691
    Abstract: Disclosed are proteinaceous molecules corresponding to an acetylation site and their use for inhibiting or reducing the nuclear localization of a nuclear localizable polypeptide, such as PD-1, PD-L1 and PD-L2. This invention also relates to the use of the proteinaceous molecules for altering at least one of (i) formation; (ii) proliferation; (iii) maintenance; (iv) epithelial to mesenchymal cell transition (EMT); or (v) mesenchymal to epithelial cell transition (MET) of a PD-1-, PD-L1- or PD-L2-overexpressing cell, and for treating or preventing a cancer in a subject.
    Type: Application
    Filed: January 15, 2019
    Publication date: October 29, 2020
    Inventors: Sudha RAO, Peter MILBURN
  • Proteinaceous compounds and uses therefor
    Patent number: 10487115
    Abstract: Disclosed are proteinaceous molecules and their use in conditions associated with PKC-? overexpression, such as cancer. More particularly, the present invention discloses proteinaceous molecules and their use in altering at least one of (i) formation; (ii) proliferation; (iii) maintenance; (iv) epithelial to mesenchymal cell transition; or (v) mesenchymal to epithelial cell transition of a PKC-? overexpressing cell.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: November 26, 2019
    Assignee: UNIVERSITY OF CANBERRA
    Inventors: Sudha Rao, Peter Milburn
  • PROTEINACEOUS COMPOUNDS AND USES THEREFOR
    Publication number: 20190040103
    Abstract: Disclosed are proteinaceous molecules and their use in conditions associated with PKC-? overexpression, such as cancer. More particularly, the present invention discloses proteinaceous molecules and their use in altering at least one of (i) formation; (ii) proliferation; (iii) maintenance; (iv) epithelial to mesenchymal cell transition; or (v) mesenchymal to epithelial cell transition of a PKC-? overexpressing cell.
    Type: Application
    Filed: February 1, 2017
    Publication date: February 7, 2019
    Inventors: Sudha RAO, Peter MILBURN